Anticancer Research

Papers
(The H4-Index of Anticancer Research is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Effects of Mixed Nuts on Colonic Cell Proliferation andPtgs2andRelaGene Expression65
Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series45
Down-regulation of SMPDL3B Inhibits the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells39
Proteomic and Metabolomic Analyses of Adipose-derived Mesenchymal Stem Cell Exosomes and Culture Supernatants36
Preface34
Andrographolide Induces ROS-dependent Apoptosis and Suppresses STAT3 Phosphorylation in Primary Effusion Lymphoma Cells32
Circulating Tumor DNA Methylation Is a Biomarker of Poor Recurrence-free Survival in Locally-Advanced Rectal Cancer27
Target-Oriented Classification of Triple-negative Breast Cancer26
Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece26
Effect of Pathological Response After Neoadjuvant Chemotherapy on Long-term Outcomes in Locally Advanced Colorectal Cancer: A Japanese Multicenter Study25
Robotic Retroperitoneal Versus Transperitoneal Partial Nephrectomy: Outcomes and Learning Curve24
Impact of Novel Agents on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer24
Therapeutic Strategies in Neurocutaneous Melanocytosis23
Artificial Intelligence Models Could Enhance the Diagnostic Accuracy (DA) of Fecal Immunochemical Test (FIT) in the Detection of Colorectal Adenoma in a Screening Setting23
Influence of Respiratory Motion on Dose Distribution in Gastric Mucosa-associated Lymphoid Tissue Lymphoma Radiotherapy22
Increased Incidence of Liver Metastases in ColorectalVersusAppendiceal Adenocarcinoma Peritonectomy Patients Despite Equivocal Survival21
Clinical Outcomes Beyond 1LEGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study ‘LUNGFUL’21
Clinical Significance of Nodal DCsign Expression in Non-small-cell Lung Cancer Patients21
Synergistic VSV Virotherapy and Carbon Nanotube Photothermal Therapy for Osteosarcoma in Murine Models21
Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome19
HOOK3 Amplification in Bladder Urothelial Carcinoma: Insights from Gene Expression and Survival Analysis19
Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy19
PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC19
0.14939498901367